• Clip
• Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> David joined a trial of treatments for asthma because he wanted to learn more about the condition, as well as to help medical research. The expenses p

David volunteered for a placebo-controlled trial of a new treatment derived from mouse DNA to improve asthma symptoms. He later discovered he was in the group taking a lower dose of the treatment, but he would not have minded being in the placebo group.

• Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> After he’d started the trial, there were scare stories about the type of treatment being tested. He felt it was too late to stop, but might have thoug

David volunteered for a placebo-controlled trial of a new treatment derived from mouse DNA to improve asthma symptoms. He later discovered he was in the group taking a lower dose of the treatment, but he would not have minded being in the placebo group.

• Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> He’d have been interested to see what happened if he had been in the placebo group. Before the trial he might have felt disappointed to get a placebo

David volunteered for a placebo-controlled trial of a new treatment derived from mouse DNA to improve asthma symptoms. He later discovered he was in the group taking a lower dose of the treatment, but he would not have minded being in the placebo group.

• Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> David had to attend several appointments for tests and a series of injections. In between he had to take his own peak flow (breathing) readings and re

David volunteered for a placebo-controlled trial of a new treatment derived from mouse DNA to improve asthma symptoms. He later discovered he was in the group taking a lower dose of the treatment, but he would not have minded being in the placebo group.

• Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> David had expected to feel like a guinea pig, but actually felt it had been interesting and worthwhile. He was pleased to have a personal debrief with

David volunteered for a placebo-controlled trial of a new treatment derived from mouse DNA to improve asthma symptoms. He later discovered he was in the group taking a lower dose of the treatment, but he would not have minded being in the placebo group.